Clover Health Investments (NASDAQ:CLOV) Given New $4.50 Price Target at Canaccord Genuity Group
Clover Health Investments (NASDAQ:CLOV – Free Report) had its target price raised by Canaccord Genuity Group from $4.20 to $4.50 in a research report report published on Monday morning,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. Separately, Craig Hallum began coverage on shares of Clover Health Investments in a report […]
Clover Health Investments (NASDAQ:CLOV – Free Report) had its target price raised by Canaccord Genuity Group from $4.20 to $4.50 in a research report report published on Monday morning,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. Separately, Craig Hallum began coverage on shares of Clover Health Investments in a report […]
